Fumiko Chino

@fumikochino.bsky.social

“Cancer pts & their families are being pulled into the #priorauthorization process, at the expense of their time, health, & well-being”

#Priorauth isn’t just an administrative hurdle for clinicians; it’s a hidden 2nd job for patients. #ascoQLTY25

@ascocancer.bsky.social
@ascopost.bsky.social

Prior Authorization Is Burdensome for Patients, Resulting in Treatment Delays, Financial Strain, and Stress

“This study makes clear what many of us in oncology have suspected: Prior authorization isn’t just an administrative hurdle for clinicians; it’s a hidden second job for patients,” noted investigators....

ascopost.com

3 5

by Fumiko Chino

by Fumiko Chino — Reposted by: Cary P. Gross

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

New in @medpagetoday.com: Financial side effects from #breastcancer treatment can create life-altering problems, including distress, debt, & employment disruptions #bcsm #financialToxicity

Proud of the work of @mdanderson.bsky.social PGY5 Dr Kamaria Lee in the @ascocancer.bsky.social
#ASCOEdBook

Kamaria Lee and Fumiko Chino on Financial Toxicity and Breast Cancer

Still needed: interventions at government, institutional, and provider levels

www.medpagetoday.com

2 2

by Fumiko Chino

by Fumiko Chino — Reposted by: Bridgette Thom

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

#Priorauthorization #UtilizationManagement for costly 2nd-line 💊 is understandable but nearly one-half of plans have quantity limits for generic ondansetron, a cheap ($16 for 60 8mg tabs) & effective 1st-line drug

Make this make sense.

#fixPriorAuth
@michaelannica.bsky.social
@jamanetworkopen.com

Prior Authorization, Quantity Limits, and Step Therapy for Antiemetics

This cross-sectional study evaluates whether antiemetic drugs for patients with cancer who have Patient Protection and Affordable Care Act (ACA) Marketplace or Medicaid plans are subject to utilizatio...

jamanetwork.com

2 3

by Fumiko Chino

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

The 2025 @ascocancer.bsky.social Quality Care Symposium #ASCOQLTY25 will feature >600 abstract presentations covering the latest implementation science and the entire spectrum of health services research.

📖 Review abstracts today!
✈️ Join us this weekend in Chicago

meetings.asco.org/abstracts-pr...

#ASCOQLTY25
Abstracts Now
Available
Explore more than 600 abstracts spanning the entire spectrum of health services research from distinguished leaders in quality care.
View Abstracts

2 5

by Fumiko Chino

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

Kirby claw machine win 🏆 #weekendsinHouston

A woman holding a Kirby plushie who is wearing a bunny costume in a claw machine room with a man playing a game in the background.

3

by Fumiko Chino

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

Francis Bacon, Gary Larson, and Neil

#weekendsinHouston

Neil in front of a famous Francis Bacon of a blurry man struggling with a door. Neil is miming pushing a door

The famous Gary Larson Farside comic of a kid trying to push a door marked pull

5

by Fumiko Chino

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

Any day I get to talk to Dr Monty Pal is a good day... even better when we get to discuss the amazing science being presented at @ascocancer.bsky.social #ASCOQLTY25!

There is still time to register and join us in Chicago next weekend Oct 10-11, 2025.
👉 www.asco.org/quality/regi...

Two people with headsets recording a podcast

1 6

by Fumiko Chino

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

Great work by a @mdanderson.bsky.social fellow on this @ascocancer.bsky.social 📄:

Lutetium-177-PSMA-617 #Lu177 #PSMA is a targeted tx option for use in metastatic castration-resistant #prostatecancer #mCRPC #pcsm. Access to #Lu177PSMA is limited by financial, logistical, & geographic barriers.

Access to Lu177-PSMA for Prostate Cancer: From Clinical Trials to the Real World

Lutetium-177-PSMA-617 is a new therapeutic modality approved for select patients with advanced prostate cancer. Many patients face access barriers because of travel burden, cost, and other logistic co...

dailynews.ascopubs.org

1 4

by Fumiko Chino

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

🧦 🥰🥰🥰

1

by Fumiko Chino

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

Phenomenal #ASTRO25 session yesterday about #AYACSM dx, tx, and survivorship concerns. I was proud to be on stage with a community doc, academic researcher, psych-oncologist, and #AYAC survivor, caregiver, and Director of an oncosurvivorship PCP clinic. @astro-org.bsky.social

5 people standing in front of a screen, 4 physicians, one psyD

1 4

by Fumiko Chino

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

The engine and the caboose of the ROI 5k this morning! Great run walk along the bay for #ASTRO25 @astro-org.bsky.social @radoncology.bsky.social

Two people holding signs. One says 8 min mile the other says "walk"

1

by Fumiko Chino

Fumiko Ladd Chino, MD FASCO

@fumikochino.bsky.social

#ASTRO25 is for cutting edge science, bold ideas, innovative tx paradigms, patient-centered frameworks, & translational work that advances future cures.

It is ALSO for fellowship, catching up with colleagues/friends, & fostering the growth of the next leaders in #radonc.

6

References

Fields & subjects